CYCLERION THERAPEUTICS
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
CYCLERION THERAPEUTICS
Industry:
Biotechnology Pharmaceutical
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.cyclerion.com
Total Employee:
101+
Status:
Active
Total Funding:
217 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Ractigen Therapeutics
Ractigen is an early-stage pharmaceutical company.
Relief Therapeutics
Relief Therapeutics is a clinical stage biotechnology company.
Reverie Labs
Reverie Labs is a machine learning-driven pharma company.
Nuevocor
Nuevocor operates as a preclinical-stage biotech company.
Nuvation Bio
Nuvation Bio is a biopharmaceutical company.
Novaremed AG
Novaremed AG is a clinical-stage Swiss biopharmaceutical company.
Verovaccines
Verovaccines is a biopharmaceutical company.
VivaVision Biotech
VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases.
Vast Therapeutics
Vast Therapeutics is an innovative, preclinical-stage pharmaceutical company .
Vyriad
Vyriad is a clinical stage biopharmaceutical company.
MetrioPharm
MetrioPharm is a clinical stage pharmaceutical development company.
Medexus Pharma
Medexus Pharma is a fully integrated specialty pharmaceutical company located in Chicago.
Microbiotix
Microbiotix, Inc. is a clinical stage biopharmaceutical company.
Molecular Partners
Molecular Partners is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Allero Therapeutics
Allero Therapeutics is a biopharmaceutical company.
Ablaze Pharmaceuticals
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.
Athenen Therapeutics
Athenen Therapeutics is a boston-based pharmaceutical company.
Amphista Therapeutics
Amphista Therapeutics operates as a biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
ArriVent Biopharma
ArriVent develops pharmaceutical products to cure presently untreatable cancer.
Aptadel Therapeutics
Aptadel Therapeutics is a pre-clinical biomedical company.
Acerus Pharmaceuticals
Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company.
Actimed Therapeutics
Actimed Therapeutics is a clinical stage biopharmaceutical company.
Sio Gene Therapies
Sio Gene Therapies is a clinical-stage biopharmaceutical company.
Amryt Pharma
Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.
Avalo Therapeutics
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Allist Pharmaceuticals
Allist Pharmaceuticals is a pharmaceutical enterprise that discovers, develops, and commercializes innovative medicines.
Eirion Therapeutics
Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription products.
EpicentRx Inc
EpicentRx Inc is a clinical-stage immuno-oncology company.
Biotherapeutics
BioTherapeutics Inc. (BTI) is a pre-clinical stage company
Basilea Pharmaceutica
Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.
Bioasis Technologies
Bioasis Technologies, Inc. is a biopharmaceutical company.
Aria Pharmaceuticals
Aria Pharmaceuticals is a artificial intelligence-driven biopharmaceutical company.
Timber Pharmaceuticals
Timber Pharmaceuticals is a privately held biopharmaceutical company.
Tessera Therapeutics
Tessera Therapeutics is a biotechnology company that focuses on a new category of genetic medicines.
Tunitas Therapeutics
Tunitas Therapeutics is a privately held biopharmaceutical company
Thetis Pharmaceuticals
Thetis Pharmaceuticals is a biopharmaceutical company.
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
Tisbury Pharmaceuticals
Tisbury Pharmaceuticals is a pre-clinical stage pharmaceutical company.
UroGen Pharma
UroGen Pharma is a clinical-stage biopharmaceutical company focused on developing novel therapies.
Kinnear Pharmaceuticals
Kinnear Pharmaceuticals is a preclinical stage pharmaceutical company.
Khondrion
Khondrion is a clinical-stage pharmaceutical company.
Sermonix Pharmaceuticals
Sermonix Pharmaceuticals is an Ohio LLC specialty pharmaceutical.
Shenzhen Salubris Pharmaceuticals
Shenzhen Salubris Pharmaceuticals is a comprehensive pharmaceutical company.
Stemson Therapeutics
Stemson Therapeutics is a pre-clinical stage cell therapy company.
SAB Biotherapeutics
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Soleno Therapeutics
Soleno Therapeutics is a clinical-stage biopharmaceutical company.
Sincerus Pharmaceuticals
Sincerus Pharmaceuticals provides sterile and non-sterile pharmaceutical compounding services.
Decoy Therapeutics
Decoy Therapeutics is a preclinical stage biotech company.
Delix Therapeutics
Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.
Halia Therapeutics
Halia is a preclinical-stage biopharmaceutical company.
Hinova Pharma
Hinova Pharma is a pharmaceutical company.
Hyloris Pharmaceuticals
Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company.
Immunophage Biotech
Immunophage Biotech is a Nanjing-based pharmaceutic company.
Immuto Scientific
Immuto Scientific is a biotechnology services company that provides analytical insights to pharmaceutical companies for drug discovery.
IMPACT Therapeutics
IMPACT Therapeutics is a China based Company.
InterveXion Therapeutics
InterveXion Therapeutics is a privately-held clinical-stage biopharmaceutical company
Immuneoncia Therapeutics
Immuneoncia Therapeutics is an immuno-oncology-centric biopharmaceutical company.
ITBMed
A Stockholm, Sweden-based biopharmaceutical company.
Gerostate Alpha
Gerostate Alpha is a pharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Osmotica Pharmaceutical
Osmotica Pharmaceutical is a global specialty pharmaceutical company.
Opiant Pharmaceuticals
Opiant Pharmaceuticals is a specialty pharmaceutical company.
Xgene Pharmaceutical
Xgene Pharmaceutical is a pharmaceutical company.
Zentera Therapeutics
Zentera Therapeutics is a biopharmaceutical company.
Zhaoke Ophthalmology Pharmaceutical
Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.
Chromis Therapeutics
Chromis Therapeutics, Inc. (Chromis) is a San Diego-based biopharmaceutical company
CytoMed Therapeutics
CytoMed Therapeutics is a cancer immunotherapy startup.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Cardurion Pharmaceuticals
Cardurion is a Boston-based cardiovascular biotechnology company
Complement Therapeutics
Complement Therapeutics operates as a preclinical stage company.
Cerevel Therapeutics
Cerevel Therapeutics is a biopharmaceutical company.
Circadian Therapeutics
Circadian Therapeutics is a Pharmaceutical company.
Centessa Pharmaceuticals
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process.
Chase Therapeutics
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Consortia Therapeutics
Consortia Therapeutics is a pre-clinical bio-therapeutics company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Cycle Pharmaceuticals
Cycle Pharmaceuticals is a pioneering pharmaceutical company.
Chord Therapeutics
Chord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases.
Caladrius Biosciences
Caladrius Biosciences is a clinical-stage biopharmaceutical company.
Promontory Therapeutics
Promontory Therapeutics is a clinical-stage pharmaceutical company focused on novel therapeutics in oncology.
Phathom Pharmaceuticals
Phathom Pharmaceuticals is a biopharmaceutical company.
Pantherna Therapeutics
Pantherna Therapeutics is a privately-held biopharmaceutical company.
Pi Therapeutics
Pi Therapeutics is a Cancer treatment company
PlantForm
PlantForm Corporation is a privately-held Canadian biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
MFN Partners
MFN Partners investment in Post-IPO Equity - Cyclerion Therapeutics
Peter M. Hecht
Peter M. Hecht investment in Post-IPO Equity - Cyclerion Therapeutics
Polaris Partners
Polaris Partners investment in Post-IPO Equity - Cyclerion Therapeutics
Slate Path Capital
Slate Path Capital investment in Post-IPO Equity - Cyclerion Therapeutics
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - Cyclerion Therapeutics
Invus
Invus investment in Post-IPO Equity - Cyclerion Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Cyclerion Therapeutics
Slate Path Capital
Slate Path Capital investment in Post-IPO Equity - Cyclerion Therapeutics
Pappas Capital
Pappas Capital investment in Post-IPO Equity - Cyclerion Therapeutics
Polaris Partners
Polaris Partners investment in Post-IPO Equity - Cyclerion Therapeutics
Official Site Inspections
http://www.cyclerion.com Semrush global rank: 3.73 M Semrush visits lastest month: 3.66 K
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cyclerion Therapeutics"
Investors & Media | Cyclerion Therapeutics, Inc.
Jul 31, 2023 The Investor Relations website contains information about Cyclerion Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Our Assets - Cyclerion
Our Assets Our current portfolio includes novel clinical-stage assets, as well as multiple research stage molecules. Concurrently, we are also evaluating other activities aimed at enhancing …See details»
Our Commitment - Cyclerion
Our Commitment We are committed to building a patient-centric company and are driven by a sense of urgency to bring meaningful treatments to patients in need.See details»
News & Events - Cyclerion Therapeutics, Inc.
Aug 7, 2024 The Investor Relations website contains information about Cyclerion Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Cyclerion - LinkedIn
Cyclerion | 3,836 followers on LinkedIn. We are a biopharmaceutical company on a mission to develop treatments for serious diseases. | Our current portfolio includes novel clinical-stage assets ...See details»
Cyclerion Therapeutics - Crunchbase
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize …See details»
Cyclerion Therapeutics, Inc. - AnnualReports.com
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for …See details»
Cyclerion - Company Profile - Tracxn
Nov 16, 2024 Cyclerion - Developer of therapies for treating sickle cell disease and diabetic nephropathy. Public Company. Raised funding over 4 rounds from 8 investors.See details»
Cyclerion Announces Mitochondrial Disease-Focused Corporate …
Oct 6, 2022 Development programs prioritized and organization structured to align with mitochondrial disease-focused strategy Plans to meet with FDA in Q4 2022 to discuss MELAS …See details»
Cyclerion Company Profile - Office Locations, Competitors, …
Oct 29, 2024 Cyclerion has 5 employees across 2 locations and $1.63 m in annual revenue in FY 2022. See insights on Cyclerion including office locations, competitors, revenue, financials, …See details»
Cyclerion Strengthens Board of Directors with Experienced …
Nov 30, 2023 Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator Cyclerion Therapeutics, Inc. Thu, Nov 30, 2023, 6:16 PM 5 min readSee details»
Cyclerion Announces Corporate Updates and Q1 2023 Financial …
May 11, 2023 Cyclerion retains full rights to olinciguat, an oral, once-daily, peripheral sGC stimulator, that has shown a favorable safety and tolerability profile, drug characteristics, and …See details»
Cyclerion Therapeutics, Inc. (CYCN) - Stock Analysis
3 days ago Get a real-time Cyclerion Therapeutics, Inc. (CYCN) stock price quote with breaking news, financials, statistics, charts and more.See details»
Board of Directors • Groups • Cyclerion
Errol De Souza, PhD, Chair 13th February 2019Peter Hecht, PhDSee details»
Cyclerion Strengthens Board of Directors with Experienced …
Nov 30, 2023 Cyclerion Therapeutics is a clinical-stage biopharmaceutical company on a mission to develop treatments for serious diseases. Cyclerion acquired 10 percent equity …See details»
Cyclerion Therapeutics Reports Third Quarter 2021 Financial …
Nov 9, 2021 Cyclerion Therapeutics is a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function. Cyclerion is advancing novel, first-in …See details»
Biotech Alert: Searches spiking for these stocks today - Nasdaq
1 day ago Cyclerion Therapeutics is a clinical-stage biopharmaceutical company that says it is “on a mission to develop treatments for serious diseases.”See details»
Our Science • Cyclerion
Cyclerion is actively evaluating other activities aimed at enhancing shareholder value, which may potentially include collaborations, licenses, mergers, acquisitions and/or other targeted …See details»
Cyclerion Reports Corporate Update and Full Year 2022 Financial …
Dec 31, 2022 The Company previously reported clinical data in adult patients with MELAS* that indicate that zagociguat may have potential as a first-ever therapy for patients with this rare, …See details»
Publications • Cyclerion
Feb 7, 2024 A Randomized, Placebo‐Controlled, Multiple‐Ascending‐Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Soluble Guanylate …See details»